ADVANCED SOFT TISSUE SARCOMA
Clinical trials for ADVANCED SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink rare sarcomas
Disease control Recruiting nowThis study tests whether combining atezolizumab (an immunotherapy) with selinexor (a drug that blocks a cancer-growth protein) can shrink tumors in people with advanced alveolar soft part sarcoma (ASPS), a rare cancer. About 27 adults whose cancer has spread or cannot be removed …
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:55 UTC
-
New combo aims to halt rare sarcomas
Disease control Recruiting nowThis study tests two drugs, pembrolizumab and cabozantinib, in people with advanced sarcomas that have not responded to standard treatments. The goal is to see if the combination can stop or shrink tumors for at least 6 months. About 119 adults with specific sarcoma types will ta…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 16, 2026 23:55 UTC
-
New hope for sarcoma: drug combo aims to slow tumor growth
Disease control Recruiting nowThis study tests a new two-drug treatment for people with advanced soft tissue sarcoma that has spread. The drugs, abemaciclib and gemcitabine, work together to stop cancer cells from multiplying. The goal is to see if this combination is safer and works better than the current s…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Can a maintenance chemo drug extend control of advanced sarcoma?
Disease control Recruiting nowThis study is for people with advanced soft tissue sarcoma whose disease is under control after standard chemotherapy. It compares ongoing treatment with a drug called pegylated liposomal doxorubicin (PLD) against simply watching and waiting. The goal is to see if maintenance PLD…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Radioactive drug targets Hard-to-Treat sarcoma in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [Ac225]-RTX-2358, in 30 adults with advanced soft tissue sarcoma that has returned or not responded to prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Partici…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC